Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis

B Li, P Li, L Wei, J Zou, Y Wang, Q You… - Journal of Medicinal …, 2024 - ACS Publications
Rheumatoid arthritis (RA) is a chronic autoimmune disease. Targeting NLRP3
inflammasome, specifically its interaction with NEK7 via the LRR domain of NLRP3, is a …

Therapeutic potential of targeting the NLRP3 inflammasome in rheumatoid arthritis

J Gao, H Zhang, Y Yang, J Tao - Inflammation, 2023 - Springer
NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is a
cytoplasmic multiprotein complex composed of the innate immune receptor protein NLRP3 …

An RRx-001 analogue with potent anti-NLRP3 inflammasome activity but without high-energy nitro functional groups

H Lin, M Yang, C Li, B Lin, X Deng, H He… - Frontiers in …, 2022 - frontiersin.org
NLRP3 inflammasome is involved in the pathology of multiple human inflammatory diseases
but there are still no clinically available medications targeting the NLRP3 inflammasome. We …

RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor

Y Chen, H He, B Lin, Y Chen, X Deng… - Cellular & molecular …, 2021 - nature.com
The NLRP3 inflammasome plays a crucial role in innate immune-mediated inflammation
and contributes to the pathogenesis of multiple autoinflammatory, metabolic and …

Recent progress on the discovery of NLRP3 inhibitors and their therapeutic potential

M Su, W Wang, F Liu, H Li - Current Medicinal Chemistry, 2021 - ingentaconnect.com
Background: Inflammation is the body's immune system's fast coordinating response to
irritants caused by pathogens, external injuries, and chemical or radiation effects. The …

Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders

H Jiang, H He, Y Chen, W Huang, J Cheng… - Journal of Experimental …, 2017 - rupress.org
The NLRP3 inflammasome has been implicated in the pathogenesis of a wide variety of
human diseases. A few compounds have been developed to inhibit NLRP3 inflammasome …

The research progression of direct NLRP3 inhibitors to treat inflammatory disorders

X Chen, P Zhang, Y Zhang, M Wei, T Tian, D Zhu… - Cellular …, 2024 - Elsevier
The NLRP3 inflammasome represents a cytoplasmic multiprotein complex with the
capability to recognize a wide range of pathogen-derived, environmental, and endogenous …

NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasome

JR Coombs, A Zamoshnikova, CL Holley… - Science …, 2024 - science.org
Inflammasomes are multiprotein complexes that drive inflammation and contribute to
protective immunity against pathogens and immune pathology in autoinflammatory …

Targeting the NLRP3 inflammasome in inflammatory diseases

MSJ Mangan, EJ Olhava, WR Roush… - Nature reviews Drug …, 2018 - nature.com
Danger signals are a hallmark of many common inflammatory diseases, and these stimuli
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …

NLRP3 inhibitors: Unleashing their therapeutic potential against inflammatory diseases

V Ramalingam - Biochemical Pharmacology, 2023 - Elsevier
The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome has been
linked to the release of pro-inflammatory cytokines and is essential for innate defence …